Parra PMY, Graham PS, García AAD

Language: Spanish
References: 14
Page: 163-167
PDF size: 155.62 Kb.

ABSTRACT

Toxic erythema is a common benign dermatological condition in newborns, it appears in the first 48 hours of life. It is usually spontaneously resolved. Currently, there are no clear epidemiological data, reporting incidences from 3.7% to 72%, so we aimed to identify the epidemiological characteristics of toxic erythema in newborns, treated at Hospital Angeles Pedregal. An analytical, observational, prospective, and longitudinal study was carried out. During the months of July to December 2020, all newborns who were admitted to the physiological nurseries of Hospital Angeles Pedregal were followed, closely monitoring the appearance of signs of toxic erythema. Of 331 newborns attended, 50.8% were women, with a mean age of 38 ± 1 SDG. The incidence rate for toxic erythema was 4.5 cases in 1,000 infants (45%). The most important risk factor was the route of birth by cesarean section RR 1.2 (95% CI 1.07-1.3). Unlike the expectant management recommendations, we observed a decrease in dermal lesions when applying topical treatment. We propose to carry out cohorts that allow a longer observation of the newborn.

REFERENCES

1. Reginatto FP, Villa DD, Cestari TF. Benign skin disease with pustules in the newborn. An Bras Dermatol. 2016; 91 (2): 124-134. doi: 10.1590/abd1806-4841.20164285.

2. Morgan AJ, Steen CJ, Schwartz RA, Janniger CK. Erythema toxicum neonatorum revisited. Cutis. 2009;83 (1):13-16.

3. Moosavi Z, Hosseini T. One-year survey of cutaneous lesions in 1000 consecutive Iranian newborns. Pediatr Dermatol. 2006; 23 (1): 61-63.

4. Sachdeva M, Kaur S, Nagpal M, Dewan SP. Cutaneous lesions in new born. Indian J Dermatol Venereol Leprol. 2002; 68 (6): 334-337.

5. Akoglu G, Ersoy Evans S, Akca T, Sahin S. An unusual presentation of erythema toxicum neonatorum: delayed onset in a preterm infant. Pediatr Dermatol. 2006; 23 (3): 301-302.

6. Barbarot SJM. Dermatología neonatal. EMC-Dermatología. 2018; 52 (1): 1-27.

7. Monteagudo B, Labandeira J, León-Muiños E, Ramírez-Santos A, Suárez-Amor O, Cabanillas M. Eritema tóxico neonatal. Piel (Barc. Ed. Impr.). 2010; 25 (9): 507-510.

8. Requena C, Febrer MI, Navarro M, Escutia B, Mari JI, Aliaga A. Eritema tóxico neonatal pustuloso. Actas Dermosifiliogr. 2000; 91(6):289-290.

9. Fernandes JD, Machado MC, Oliveira ZN. Children and newborn skin care and prevention. An Bras Dermatol. 2011; 86 (1): 102-110. doi: 10.1590/s0365-05962011000100014.

10. Lund C, Kuller J, Lane A, Lott JW, Raines DA. Neonatal skin care: the scientific basis for practice. Neonatal Netw. 1999; 18 (4): 15-27.

11. Magaña M, Valerio J, Mateo A, Magaña-Lozano M. Alteraciones cutáneas del neonato en dos grupos de población de México. Bol Med Hosp Infant Mex. 2005; 62 (2): 117-23.

12. Reginatto FP, DeVilla D, Muller FM, Peruzzo J, Peres LP, Steglich RB et al. Prevalence and characterization of neonatal skin disorders in the first 72h of life. J Pediatr. 2017; 93 (3):238-245.

13. Liu C, Feng J, Qu R, Zhou H, Ma H, Niu X et al. Epidemiologic study of the predisposing factors in erythema toxicum neonatorum. Dermatology. 2005; 210 (4): 269-272.

14. González Echeverría F, Martínez Rodríguez J, Ancin Chandia T, Córdova Iturriaga A. ¿Es el eritema tóxico neonatal un factor de riesgo en el desarrollo de la alergia en la infancia? An Esp Pediatr. 1997; 47 (5): 515-520.